$ACNT

Ascent Industries (ACNT) Q2 2026 Earnings Call Transcript

Ascent Industries (ACNT) reported Q2 2026 net sales of $25.7 million, up 37.6% year over year, and adjusted EBITDA of $1.5 million versus a prior-year loss. Volume rose 15.2% and average selling prices rose about 23%. Liquidity was $46 million. The Midwest Graphic Sales acquisition added $1.9 million in sales and $300,000 adjusted EBITDA.

Original reporting
Published Aug 12, 2026, 2:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 3:09 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ascent Industries (ACNT) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ACNTBullishMed
01

Why it matters

Traders can update models around the EBITDA turnaround, margin trajectory (including expected Q4 contraction), and cash conversion cycle targets, especially given the Midwest acquisition contribution and ongoing working-capital investment.

02

Market read

The transcript adds decision-useful operating metrics (revenue/EBITDA inflection, pipeline and conversion, SG&A efficiency, and cash conversion cycle) that can affect near-term valuation and positioning.

03

What to watch

Working capital remains a cash drag, with operating cash flow negative in H1 and cash conversion cycle up 12 days; the $1.5M cash release target depends on execution of the cash conversion initiative.

Relevance 8/10Novelty 7/10Timing: after-hours earnings call transcript (Aug. 4, 2026)

Background

This is a Q2 2026 earnings call transcript for Ascent Industries, covering financial results, acquisition integration, pipeline conversion, margin, and liquidity/cash flow.

Company-level read

Ticker impact

$ACNTBullishMedium confidence
Context

Ascent reported Q2 2026 net sales of $25.7M (+37.6% YoY) and adjusted EBITDA of $1.5M after a prior-year loss, plus record $140M sales pipeline.

Expected impact

Moderately positive bias for the next few sessions, with follow-through dependent on whether margin contraction in Q4 and working-capital cash use reverse.

Evidence & confidence

Multiple company-specific metrics improved simultaneously (revenue, EBITDA, volume/pricing, pipeline, SG&A as % of sales), but gross margin is expected to contract seasonally in Q4 and operating cash flow used $7.7M in H1, adding uncertainty.

Market effects

Signals demand and execution strength in specialty chemicals/custom manufacturing despite a “soft” market backdrop, which may modestly support sentiment for similar operators.

No specific regional read-through beyond general specialty-chemicals demand.

Petroleum-based input exposure (65% of raw material spend) highlights sensitivity to global energy and freight volatility, but no new macro shock is disclosed.

Counterpoint

Gross margin is down YoY (21.6% vs 26.1%) and management expects moderate Q4 contraction, so the EBITDA improvement may not persist at the same rate.

Key entities

  • Ascent Industries Co.

    Reported Q2 2026 results including $25.7M net sales (+37.6% YoY) and $1.5M adjusted EBITDA, plus record $140M sales pipeline and liquidity of $46M.

  • Midwest Graphic Sales

    Contributed $1.9M sales and $0.3M adjusted EBITDA in the two months after its May 4, 2026 closing; back-office integration completed a full quarter early.

Related articles

$ACNTMed

ASCENT INDUSTRIES CO. (ACNT): Results of Operations and Financial Condition

ASCENT INDUSTRIES CO. (ACNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 acnt-20260630ex991.htm EX-99.1 Document Exhibit 99.1 Ascent Industries Reports Second Quarter 2026 Results; Year-Over-Year Net Sales Increase 37.6% and Adjusted EBITDA Improves by $1.8 Million Sequentially, legacy net sales increased approximately 22% and gross margin e

$ACNTMed

Ascent Industries Pitches Pure-Play Chemicals Shift, Buybacks and Growth Runway

Ascent Industries (NASDAQ:ACNT) said it is intentionally shifting revenue from custom manufacturing toward product sales, which it expects to be more predictable and margin accretive. Product sales rose from ~10% of sales in 2023 to ~27% in 2024 and ~30% last year. Management cited $7M and $10M net-new business from recent customer wins, underutilized assets (~45% utilization), and a $14M Midwest Graphic Sales acquisition (closed early May) with $10.8M revenue and ~$2M adjusted EBITDA.

$AGLMed

Why is AGL Energy stock surging today?

AGL Energy shares rose 5.4% to A$8.6 after the company reported FY26 results. Underlying EBITDA increased 2% to A$2.10 billion, operating free cash flow rose 60% to A$850 million, and profit after tax was A$756 million. It declared a fully franked final dividend of 26 cents, taking FY26 total to 50 cents, and guided FY27 payout ratio of 55–60%.

$IMSRMed

Terrestrial Energy (IMSR) Q2 2026 Earnings Call Transcript

Terrestrial Energy (IMSR) held its Q2 2026 earnings call, reporting $283.4 million cash and investments as of June 30, 2026, and quarterly cash burn of $6.4 million. The company estimated $2.7 billion lifetime revenue per IMSR plant, with blended gross margin of 33%. Net loss was $9.4 million. It cited NRC licensing progress and a Texas A&M RELLIS site lease.

$PGENMed

Precigen (PGEN) Q2 2026 Earnings Call Transcript

Precigen (PGEN) reported Q2 2026 PAPZIMEOS net revenue of $53.1 million, up 145.8% sequentially from $21.6 million, and first quarterly net income of $20.1 million, or $0.05 per diluted share. Gross margin was 95% but management expects normalization to high 80% to low 90%. Cash and investments were $38.7 million at June 30, 2026.

$LEGNMedAI 8/10

Legend Biotech (LEGN) Q2 2026 Earnings Call Transcript

Legend Biotech (LEGN) reported Q2 2026 results on an earnings call. Worldwide CARVYKTI net trade sales were $657 million, up 50% YoY. Total revenue was $387.5 million, up 52% YoY, with adjusted net income of $63.1 million ($0.16/share). Cash was $965 million. Q3 gross margin guidance was in the lower 50% range.